Clinical and Prognostic Significance of Signal Transducer and Activator of Transcription 3 and Mucin 1 in Patients With Non-Small Cell Lung Cancer Following Surgery

Oncology Letters - Greece
doi 10.3892/ol.2018.7858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2009English

Laricitrin Ameliorates Lung Cancer-Mediated Dendritic Cell Suppression by Inhibiting Signal Transducer and Activator of Transcription 3

Oncotarget
Oncology
2016English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2013English

STAT3 (Signal Transducer and Activator of Transcription 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Clinical and Prognostic Significance of R282W P53 Gene Mutation in North India Patients With Non Small Cell Lung Cancer

Translational Medicine
2012English

Expression and Clinical Significance of IGF-1, IGFBP-3, and IGFBP-7 in Serum and Lung Cancer Tissues From Patients With Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy